In addition, we observed an elevated NF-κB signaling score in drug-treated tumor epithelial populations compared to naïve tumor epithelial populations (Fig. 2j), supporting a potential role of elevated NF-κB signaling in mediating therapy resistance. Here, NFKB1 is linked to neoplasm.